US EditionGlobalData highlights implications of US tariffs on IVD market
Summary by Express Healthcare
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
GlobalData highlights implications of US tariffs on IVD market
On April 2, the Trump administration announced tariffs on most US trading partners, including 125 per cent on China, 31 per cent on Switzerland, and 20 per cent on the EU. Days later, Trump announced a 90-day pause on some tariffs, but a 10 per cent baseline tariff remains. These tariffs are expected to impact all 510(k)-approved medical devices manufactured outside of the US (OUS). Thus, companies with OUS manufacturing will be affected by tari…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
